110 related articles for article (PubMed ID: 8940634)
1. Targeting retrovirus entry.
Cosset FL; Russell SJ
Gene Ther; 1996 Nov; 3(11):946-56. PubMed ID: 8940634
[TBL] [Abstract][Full Text] [Related]
2. Modifying the host range properties of retroviral vectors.
Russell SJ; Cosset FL
J Gene Med; 1999; 1(5):300-11. PubMed ID: 10738547
[TBL] [Abstract][Full Text] [Related]
3. Design of retroviral vectors and helper cells for gene therapy.
Hu WS; Pathak VK
Pharmacol Rev; 2000 Dec; 52(4):493-511. PubMed ID: 11121508
[TBL] [Abstract][Full Text] [Related]
4. Retroviral cell targeting vectors.
Buchholz CJ; Stitz J; Cichutek K
Curr Opin Mol Ther; 1999 Oct; 1(5):613-21. PubMed ID: 11249668
[TBL] [Abstract][Full Text] [Related]
5. Towards efficient cell targeting by recombinant retroviruses.
Marin M; Noël D; Piechaczyk M
Mol Med Today; 1997 Sep; 3(9):396-403. PubMed ID: 9302690
[TBL] [Abstract][Full Text] [Related]
6. Targeting of retroviral vectors through protease-substrate interactions.
Nilson BH; Morling FJ; Cosset FL; Russell SJ
Gene Ther; 1996 Apr; 3(4):280-6. PubMed ID: 8732159
[TBL] [Abstract][Full Text] [Related]
7. A retroviral vector capable of targeted gene transfer into cells expressing HIV envelope glycoprotein.
Suzuki S; Shimada T
Biochem Biophys Res Commun; 2000 May; 271(3):672-6. PubMed ID: 10814520
[TBL] [Abstract][Full Text] [Related]
8. MLV-derived retroviral vectors selective for CD4-expressing cells and resistant to neutralization by sera from HIV-infected patients.
Stitz J; Steidl S; Merget-Millitzer H; König R; Müller P; Nocken F; Engelstädter M; Bobkova M; Schmitt I; Kurth R; Buchholz CJ; Cichutek K
Virology; 2000 Feb; 267(2):229-36. PubMed ID: 10662618
[TBL] [Abstract][Full Text] [Related]
9. Retroviral targeting of proliferating endothelial cells.
Gornikiewicz A; Zommer A; Jakesz R; Gnant M; Brostjan C
Acta Biochim Pol; 2005; 52(3):731-5. PubMed ID: 16175248
[TBL] [Abstract][Full Text] [Related]
10. Retroviral targeted delivery.
Schnierle BS; Groner B
Gene Ther; 1996 Dec; 3(12):1069-73. PubMed ID: 8986432
[TBL] [Abstract][Full Text] [Related]
11. A retroviral packaging cell line for pseudotype vectors based on glioma-infiltrating progenitor cells.
Fischer YH; Miletic H; Giroglou T; Litwak S; Stenzel W; Neumann H; von Laer D
J Gene Med; 2007 May; 9(5):335-44. PubMed ID: 17474071
[TBL] [Abstract][Full Text] [Related]
12. Intracellular trafficking of retroviral vectors: obstacles and advances.
Anderson JL; Hope TJ
Gene Ther; 2005 Dec; 12(23):1667-78. PubMed ID: 16292352
[TBL] [Abstract][Full Text] [Related]
13. Retroviral vector targeting for gene therapy.
Günzburg WH; Fleuchaus A; Saller R; Salmons B
Cytokines Mol Ther; 1996 Sep; 2(3):177-84. PubMed ID: 9384702
[TBL] [Abstract][Full Text] [Related]
14. Tumor cell-specific gene transfer with retroviral vectors displaying single-chain antibody.
Tang Y; Li Y; Qian G
Chin Med J (Engl); 2002 Jul; 115(7):1064-9. PubMed ID: 12150744
[TBL] [Abstract][Full Text] [Related]
15. Use of VSV-G pseudotyped retroviral vectors to target murine osteoprogenitor cells.
Kalajzic I; Stover ML; Liu P; Kalajzic Z; Rowe DW; Lichtler AC
Virology; 2001 May; 284(1):37-45. PubMed ID: 11352666
[TBL] [Abstract][Full Text] [Related]
16. Retroviral bicistronic vectors.
Pfützner W
Drug News Perspect; 2008 Nov; 21(9):473-80. PubMed ID: 19180265
[TBL] [Abstract][Full Text] [Related]
17. Characterization of an alternative packaging system derived from the cat RD114 retrovirus for gene delivery.
Ghani K; Cottin S; de Campos-Lima PO; Caron MC; Caruso M
J Gene Med; 2009 Aug; 11(8):664-9. PubMed ID: 19507185
[TBL] [Abstract][Full Text] [Related]
18. Receptor co-operation in retrovirus entry: recruitment of an auxiliary entry mechanism after retargeted binding.
Valsesia-Wittmann S; Morling FJ; Hatziioannou T; Russell SJ; Cosset FL
EMBO J; 1997 Mar; 16(6):1214-23. PubMed ID: 9135138
[TBL] [Abstract][Full Text] [Related]
19. Improved gene transfer selectivity to hepatocarcinoma cells by retrovirus vector displaying single-chain variable fragment antibody against c-Met.
Nguyen TH; Loux N; Dagher I; Vons C; Carey K; Briand P; Hadchouel M; Franco D; Jouanneau J; Schwall R; Weber A
Cancer Gene Ther; 2003 Nov; 10(11):840-9. PubMed ID: 14605670
[TBL] [Abstract][Full Text] [Related]
20. Selective transduction of protease-rich tumors by matrix-metalloproteinase-targeted retroviral vectors.
Peng KW; Vile R; Cosset FL; Russell S
Gene Ther; 1999 Sep; 6(9):1552-7. PubMed ID: 10490764
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
